Neuron-released oligomeric α-synuclein is an endogenous agonist of TLR2 for paracrine activation of microglia

Kim, Changyoun, Ho, Dong-Hwan, Suk, Ji-Eun, You, Sungyong, Michael, Sarah, Kang, Junghee, Joong Lee, Sung, Masliah, Eliezer +3 more·2013·Nature Communications

Cited by (863)

Items 301–400 of 863

  1. Inflammatory pre-conditioning restricts the seeded induction of α-synuclein pathology in wild type mice
    Emily J. Koller, Mieu Brooks, Todd Eliot Golde, Benoit I. Giasson, Paramita Chakrabarty · 2017 · Molecular Neurodegeneration
  2. Paraquat and maneb co-exposure induces noradrenergic locus coeruleus neurodegeneration through NADPH oxidase-mediated microglial activation
    Liyan Hou, Cong Zhang, Ke Wang, Xiaofang Liu, Hongwei Wang, Yuning Che, Fuqiang Sun, Xueying Zhou, Xiulan Zhao, Qingshan Wang · 2017 · Toxicology
  3. Quality Over Quantity: Advantages of Using Alpha-Synuclein Preformed Fibril Triggered Synucleinopathy to Model Idiopathic Parkinson’s Disease
    Megan F. Duffy, Timothy J. Collier, Joseph R. Patterson, Christopher J. Kemp, D. Luke Fischer, Anna C. Stoll, Caryl E. Sortwell · 2018 · Frontiers in Neuroscience
  4. Activated microglia facilitate the transmission of α-synuclein in Parkinson's disease
    Tingting Zheng, Zhengxiang Zhang · 2021 · Neurochemistry International
  5. An Efficient Procedure for Removal and Inactivation of Alpha-Synuclein Assemblies from Laboratory Materials
    Bousset, Luc, Brundin, Patrik, Böckmann, Anja, Meier, Beat, Melki, Ronald · 2016 · Journal of Parkinson’s Disease
  6. Antioxidant Nanoparticles for Concerted Inhibition of α-Synuclein Fibrillization, and Attenuation of Microglial Intracellular Aggregation and Activation
    Nanxia Zhao, Xue Yang, Hannah R. Calvelli, Yue Cao, Nicola Louise Francis, Rebecca Chmielowski, Laurie B. Joseph, Zhiping P. Pang, Kathryn E. Uhrich, Jean Baum et al. · 2020 · Frontiers in Bioengineering and Biotechnology
  7. Proteostasis of α-Synuclein and Its Role in the Pathogenesis of Parkinson’s Disease
    Deqiang Han, Wei Zheng, Xueyao Wang, Zhiguo Chen · 2020 · Frontiers in Cellular Neuroscience
  8. Brain clearance of protein aggregates: a close-up on astrocytes
    Veronica Giusti, Gurkirat Kaur, Elena Giusto, Laura Civiero · 2024 · Molecular Neurodegeneration
  9. Mechanism of Anti-α-Synuclein Immunotherapy
    Jun Sung Lee, Seung‐Jae Lee · 2016 · Journal of Movement Disorders
  10. Neurons and Glia Interplay in α-Synucleinopathies
    Panagiota Mavroeidi, Maria Xilouri · 2021 · International Journal of Molecular Sciences
  11. Association of Glial Activation and α-Synuclein Pathology in Parkinson’s Disease
    Rui Wang, Haigang Ren, Elena V. Kaznacheyeva, Xiaojun Lu, Guanghui Wang · 2022 · Neuroscience Bulletin
  12. Regulation of α-synuclein homeostasis and inflammasome activation by microglial autophagy
    Insup Choi, George R. Heaton, You-Kyung Lee, Zhenyu Yue · 2022 · Science Advances
  13. Innate immunity and cellular senescence: The good and the bad in the developmental and aged brain
    Santoro, Antonietta, Spinelli, Chiara Carmela, Martucciello, Stefania, Nori, Stefania Lucia, Capunzo, Mario, Puca, Annibale Alessandro, Ciaglia, Elena · 2018 · Journal of Leukocyte Biology
  14. Regulation of microglia by glutamate and its signal pathway in neurodegenerative diseases
    Xinyue Zhang, Dan Wang, Bo Zhang, Jie Zhu, Zhulin Zhou, Li Cui · 2020 · Drug Discovery Today
  15. The Role of Cysteine Protease Cathepsins B, H, C, and X/Z in Neurodegenerative Diseases and Cancer
    V. Stoka, O. Vasiljeva, Hiroshi Nakanishi, Vito Turk · 2023 · International Journal of Molecular Sciences
  16. Parkinson’s disease-derived α-synuclein assemblies combined with chronic-type inflammatory cues promote a neurotoxic microglial phenotype
    Cansu Yildirim-Balatan, Alexis Fenyi, Pierre Besnault, Lina Gomez, Julia Elisa Sepulveda-Diaz, Patrick Pierre Michel, Ronald Melki, Stéphane Hunot · 2024 · Journal of Neuroinflammation
  17. The Toll-Like Receptor Radical Cycle Pathway: A New Drug Target in Immune-Related Chronic Fatigue
    Kurt Lucas, Gerwyn Morris, George Anderson, Michael H. J. Maes · 2015 · CNS & Neurological Disorders - Drug Targets
  18. Asiatic acid attenuated apoptotic and inflammatory stress in the striatum of MPTP-treated mice
    Pei‐Chun Chao, Hsiang‐Lin Lee, Mei-Chin Yin · 2016 · Food & Function
  19. Oxidative stress and α-synuclein conspire in vulnerable neurons to promote Parkinson’s disease progression
    Kelvin C. Luk · 2019 · Journal of Clinical Investigation
  20. Dopamine Receptor D5 Signaling Plays a Dual Role in Experimental Autoimmune Encephalomyelitis Potentiating Th17-Mediated Immunity and Favoring Suppressive Activity of Regulatory T-Cells
    Francisco Osorio‐Barrios, Carolina E. Prado, Francisco Contreras, Rodrigo Pacheco · 2018 · Frontiers in Cellular Neuroscience
  21. Alpha-synuclein activates the classical complement pathway and mediates complement-dependent cell toxicity
    Emil Gregersen, Cristine Betzer, Woojin Scott Kim, Gergő E. Kovács, Lasse Reimer, Glenda Margaret Halliday, Steffen Thiel, Poul Henning Jensen · 2021 · Journal of Neuroinflammation
  22. Nanomaterials as Microglia Modulators in the Treatment of Central Nervous System Disorders
    Matteo Battaglini, Attilio Marino, Margherita Montorsi, Alessio Carmignani, Maria Cristina Ceccarelli, Gianni Ciofani · 2023 · Advanced Healthcare Materials
  23. MicroRNA-100-5p and microRNA-298-5p released from apoptotic cortical neurons are endogenous Toll-like receptor 7/8 ligands that contribute to neurodegeneration
    Thomas Wallach, Zoé J. Mossmann, Michal Szczepek, Max Wetzel, Rui S. R. Machado, Martin Raden, Milad Miladi, Gunnar Kleinau, Christina Krüger, Paul Dembny et al. · 2021 · Molecular Neurodegeneration
  24. Mechanisms of long-term cognitive dysfunction of sepsis: from blood-borne leukocytes to glial cells
    Monique Michels, Amanda Valnier Steckert, João Quevedo, Tatiana Barichello, Felipe Dal‐Pizzol · 2015 · Intensive Care Medicine Experimental
  25. Aging modulates microglia phenotypes in neuroinflammation of MPTP-PD mice
    Kai Yao, Yongfei Zhao · 2018 · Experimental Gerontology
  26. The unlikely partnership between LRRK 2 and α‐synuclein in Parkinson's disease
    Noémie Cresto, Camille Gardier, Francesco Gubinelli, Marie‐Claude Gaillard, Géraldine Liot, West Andrew B, Emmanuel Brouillet · 2018 · European Journal of Neuroscience
  27. Implications of the Human Gut–Brain and Gut–Cancer Axes for Future Nanomedicine
    Ibrahim Javed, Xuejing Cui, Xiaoyu Wang, Monika Mortimer, Nikolaos K. Andrikopoulos, Yuhuan Li, Thomas Paul Davis, Yuliang Zhao, Pu Chun Ke, Chunying Chen · 2020 · ACS Nano
  28. Acylated Ghrelin as a Multi-Targeted Therapy for Alzheimer's and Parkinson's Disease
    Reich, Niklas, Hölscher, Christian · 2020 · Frontiers in Neuroscience
  29. Brain Endothelial P-Glycoprotein Level Is Reduced in Parkinson’s Disease via a Vitamin D Receptor-Dependent Pathway
    Hyojung Kim, Jeong‐Yong Shin, Yun‐Song Lee, Seung Pil Yun, Han‐Joo Maeng, Yunjong Lee · 2020 · International Journal of Molecular Sciences
  30. Impact of Microbiome–Brain Communication on Neuroinflammation and Neurodegeneration
    Iris Stolzer, Eveline Scherer, Patrick Süß, Veit Rothhammer, Beate Winner, Markus Friedrich Neurath, Claudia Günther · 2023 · International Journal of Molecular Sciences
  31. Aplp1 interacts with Lag3 to facilitate transmission of pathologic α-synuclein
    Xiaobo Mao, Hao Gu, Donghoon Kim, Yasuyoshi Kimura, Ning Wang, Enquan Xu, Ramhari Kumbhar, Xiaotian Ming, Haibo Wang, Chan Chen et al. · 2024 · Nature Communications
  32. Oxidative Stress: Pathological Driver in Chronic Neurodegenerative Diseases
    Zhao Zhong Chong, Nizar Souayah · 2025 · Antioxidants
  33. Complex Interaction between Resident Microbiota and Misfolded Proteins: Role in Neuroinflammation and Neurodegeneration
    Juliana González-Sanmiguel, Christina Maria Anna Pia Schuh, Carola Muñoz-Montesino, Pamina Contreras‐Kallens, Luis Gerardo Aguayo, Sebastian D Aguayo · 2020 · Cells
  34. Glial Purinergic Signaling in Neurodegeneration
    Marie J. Pietrowski, Amr Ahmed Gabr, Stanislav O. Kozlov, David L Blum, Annett Halle, Kévin Carvalho · 2021 · Frontiers in Neurology
  35. Genetic Defects and Pro-inflammatory Cytokines in Parkinson's Disease
    Magnusen, Albert Frank, Hatton, Shelby Loraine, Rani, Reena, Pandey, Manoj Kumar · 2021 · Frontiers in Neurology
  36. Extracellular Alpha-Synuclein: Mechanisms for Glial Cell Internalization and Activation
    Chavarría, Cecilia, Ivagnes, Rodrigo, Souza, José M. · 2022 · Biomolecules
  37. Quantitative super-resolution imaging of pathological aggregates reveals distinct toxicity profiles in different synucleinopathies
    Michael J. Morten, Liina Sirvio, Huzefa Rupawala, Emma Mee Hayes, Aitor Franco, Carola I. Radulescu, Liming Ying, Samuel J. Barnes, Arturo Muga, Yu Ye · 2022 · Proceedings of the National Academy of Sciences
  38. SARS‐COV‐2 infection and Parkinson's disease: Possible links and perspectives
    Hayder Mutter Al-Kuraishy, Ali Ismail Al-Gareeb, Ajeet Kumar Kaushik, Małgorzata Kujawska, Eman Ahmed, Gaber El‐Saber Batiha · 2023 · Journal of Neuroscience Research
  39. The role of TLR2/JNK/NF-κB pathway in amyloid β peptide-induced inflammatory response in mouse NG108-15 neural cells
    Wei Lin, Ming Ding, Jianqin Xue, Wenhui Leng · 2013 · International Immunopharmacology
  40. Anti-inflammatory and anti-oxidant mechanisms of an MMP-8 inhibitor in lipoteichoic acid-stimulated rat primary astrocytes: involvement of NF-κB, Nrf2, and PPAR-γ signaling pathways
    Eun-Jung Lee, Jin‐Sun Park, Yu‐Young Lee, Do-Yeon Kim, Jihee Lee Kang, Hee-Sun Kim · 2018 · Journal of Neuroinflammation
  41. MicroRNAs Play a Role in Parkinson’s Disease by Regulating Microglia Function: From Pathogenetic Involvement to Therapeutic Potential
    Li, Silu, Bi, Guorong, Han, Shunchang, Huang, Rui · 2022 · Frontiers in Molecular Neuroscience
  42. Prevalence of Concomitant Pathologies in Parkinson’s Disease: Implications for Prognosis, Diagnosis, and Insights into Common Pathogenic Mechanisms
    Lauren Walker, Johannes Attems · 2023 · Journal of Parkinson s Disease
  43. Alpha-Synuclein and Microglia in Parkinson’s Disease: From Pathogenesis to Therapeutic Prospects
    Hyemi Eo, Sehwan Kim, Un Ju Jung, Sang Ryong Kim · 2024 · Journal of Clinical Medicine
  44. Hypoestoxide reduces neuroinflammation and α-synuclein accumulation in a mouse model of Parkinson’s disease
    Kim, Changyoun, Ojo-Amaize, Emmanuel, Spencer, Brian, Rockenstein, Edward, Mante, Michael, Desplats, Paula, Wrasidlo, Wolf, Adame, Anthony, Nchekwube, Emeka, Oyemade, Olusola et al. · 2015 · Journal of Neuroinflammation
  45. Molecular events underlying the cell‐to‐cell transmission of α‐synuclein
    Yu Ree Choi, Soojin Park, Sang Myun Park · 2020 · FEBS Journal
  46. NLRP3 Inflammasome-Related Proteins Are Upregulated in the Putamen of Patients With Multiple System Atrophy
    Li, Fangzhou, Ayaki, Takashi, Maki, Takakuni, Sawamoto, Nobukatsu, Takahashi, Ryosuke · 2018 · Journal of Neuropathology & Experimental Neurology
  47. MerTK is a mediator of alpha-synuclein fibril uptake by human microglia
    Marie‐France Dorion, Moein Yaqubi, Konstantin A. Senkevich, Nicholas W. Kieran, Adam MacDonald, Carol X.‐Q. Chen, Wen Luo, Amber Wallis, Irina Shlaifer, Jeffery Alan Hall et al. · 2023 · Brain
  48. Altered Expression Patterns of Inflammation-Associated and Trophic Molecules in Substantia Nigra and Striatum Brain Samples from Parkinson's Disease, Incidental Lewy Body Disease and Normal Control Cases
    Douglas G. Walker, Lih‐Fen Lue, Geidy E. Serrano, Charles H. Adler, John N. Caviness, Lucia I. Sue, Thomas G. Beach · 2016 · Frontiers in Neuroscience
  49. PKC Delta Activation Promotes Endoplasmic Reticulum Stress (ERS) and NLR Family Pyrin Domain-Containing 3 (NLRP3) Inflammasome Activation Subsequent to Asynuclein-Induced Microglial Activation: Involvement of Thioredoxin-Interacting Protein (TXNIP)/Thioredoxin (Trx) Redoxisome Pathway
    Manikandan Samidurai, Bharathi N. Palanisamy, Alejandra Bargues-Carot, Monica Hepker, Naveen Chandra Kondru, Sireesha Manne, Gary D. Zenitsky, Huajun Jin, Vellareddy Anantharam, Anumantha G. Kanthasamy et al. · 2021 · Frontiers in Aging Neuroscience
  50. Vaccination strategies in tauopathies and synucleinopathies
    Anne Kristin Braczynski, Jörg Bernhard Schulz, Jan‐Philipp Bach · 2017 · Journal of Neurochemistry
  51. Novel Immunotherapeutic Approaches to Target Alpha-Synuclein and Related Neuroinflammation in Parkinson’s Disease
    Maria Angela Samis Zella, Judith Metzdorf, Friederike Ostendorf, Fabian Maass, Siegfried Muhlack, Ralf Gold, Aiden Haghikia, Lars Tönges · 2019 · Cells
  52. The Unfolded Protein Response in Immune Cells as an Emerging Regulator of Neuroinflammation
    Dominique Fernández, Antonia Geisse, José Ignacio Bernales, Alonso Lira, F. Osorio · 2021 · Frontiers in Aging Neuroscience
  53. Conformational Dynamics of an α-Synuclein Fibril upon Receptor Binding Revealed by Insensitive Nuclei Enhanced by Polarization Transfer-Based Solid-State Nuclear Magnetic Resonance and Cryo-Electron Microscopy
    Shengnan Zhang, Juan Li, Qianhui Xu, Wencheng Xia, Youqi Tao, Chaowei Shi, Dan Li, ShengQi Xiang, Cong Liu · 2023 · Journal of the American Chemical Society
  54. Inhibition of p38α MAPK restores neuronal p38γ MAPK and ameliorates synaptic degeneration in a mouse model of DLB/PD
    Michiyo Iba, Changyoun Kim, Somin Kwon, Marcell P. Szabo, Liam Horan-Portelance, Cody J. Peer, William Douglas Figg, Xylena Reed, Jinhui Ding, Seung‐Jae Lee et al. · 2023 · Science Translational Medicine
  55. Cholecystokinin (CCK): a neuromodulator with therapeutic potential in Alzheimer’s and Parkinson’s disease
    Niklas Reich, Christian Hölscher · 2024 · Frontiers in Neuroendocrinology
  56. Therapeutic implications of how TNF links apolipoprotein E, phosphorylated tau, α‐synuclein, amyloid‐β and insulin resistance in neurodegenerative diseases
    Ian A. Clark, Bryce Vissel · 2018 · British Journal of Pharmacology
  57. Translation Imaging in Parkinson’s Disease: Focus on Neuroinflammation
    S. Belloli, M. Morari, Valentina Murtaj, S. Valtorta, R. Moresco, M. Gilardi · 2020 · Frontiers in Aging Neuroscience
  58. Necrosulfonamide exerts neuroprotective effect by inhibiting necroptosis, neuroinflammation, and α-synuclein oligomerization in a subacute MPTP mouse model of Parkinson’s disease
    Yea‐Hyun Leem, Do‐Yeon Kim, Jung‐Eun Park, Hee-Sun Kim · 2023 · Scientific Reports
  59. Microglial Depletion, a New Tool in Neuroinflammatory Disorders: Comparison of Pharmacological Inhibitors of the CSF ‐ 1R
    David Guenoun, Nathan Blaise, Alexandre Sellam, Julie Roupret‐Serzec, Alice Jacquens, Juliette Van Steenwinckel, Pierre Gressèns, Cindy Bokobza · 2024 · Glia
  60. Toxoplasma gondii exposure may modulate the influence of TLR2 genetic variation on bipolar disorder: a gene–environment interaction study
    José Oliveira, Rémi Kazma, Édith Le Floch, Mériem Bennabi, Nora Hamdani, Djaouïda Bengoufa, Mehdi Dahoun, Céline Manier, Frank Bellivier, Rajagopal Krishnamoorthy et al. · 2016 · International Journal of Bipolar Disorders
  61. Glial activation precedes alpha-synuclein pathology in a mouse model of Parkinson’s disease
    María Izco, Javier Blesa, Guglielmo Verona, J Allen D Cooper, Lydia Alvarez‐Erviti · 2020 · Neuroscience Research
  62. Genetic Imaging of Neuroinflammation in Parkinson’s Disease: Recent Advancements
    Longping Yao, Jiayu Wu, Sümeyye Koç, Guohui Lu · 2021 · Frontiers in Cell and Developmental Biology
  63. Association between toll-like receptor 2 gene diversity and early-onset bipolar disorder
    José Oliveira, Nora Hamdani, Marc Busson, Bruno Étain, Mériem Bennabi, Kahina Amokrane, Wahid Boukouaci, Catherine Fortier, François Marzais, Djaouïda Bengoufa et al. · 2014 · Journal of Affective Disorders
  64. The role of innate immunity and inflammation in Parkinson´s disease
    Maria Öberg, Ivo Fabrik, Daniela Fabriková, Nina Zehetner, Anetta Härtlová · 2021 · Scandinavian Journal of Immunology
  65. Porphyromonas gingivalis: a potential trigger of neurodegenerative disease
    Ziyan Huang, Miao Hao, Naixu Shi, Xinyu Wang, Yuan Lin, Haotian Yuan, Xiaofeng Wang · 2025 · Frontiers in Immunology
  66. Protein Partners of α‐Synuclein in Health and Disease
    Louise Berkhoudt Lassen, Lasse Reimer, Nelson Ferreira, Cristine Betzer, Poul Henning Jensen · 2016 · Brain Pathology
  67. Cerebral sterile inflammation in neurodegenerative diseases
    Otani, Kento, Shichita, Takashi · 2020 · Inflammation and Regeneration
  68. RETRACTED ARTICLE: Effects of innate immune receptor stimulation on extracellular α-synuclein uptake and degradation by brain resident cells
    Changyoun Kim, Somin Kwon, Michiyo Iba, Brian J. Spencer, Edward M. Rockenstein, Michael Mante, Anthony Adame, Soo Jean Shin, Jerel Adam Fields, Robert A. Rissman et al. · 2021 · Experimental & Molecular Medicine · Retracted
  69. Immune Regulatory Functions of Macrophages and Microglia in Central Nervous System Diseases
    Michael Poppell, Grace Hammel, Yi Ren · 2023 · International Journal of Molecular Sciences
  70. Biophysical groundwork as a hinge to unravel the biology of α-synuclein aggregation and toxicity
    Nicoletta Plotegher, Elisa Greggio, Marco Bisaglia, Luigi Bubacco · 2014 · Quarterly Reviews of Biophysics
  71. Nicotinamide Adenine Dinucleotide Phosphate Oxidase and Neurodegenerative Diseases: Mechanisms and Therapy
    Liyan Hou, Lin Zhang, Jau‐Shyong Hong, Dan Zhang, Jie Zhao, Qingshan Wang · 2020 · Antioxidants and Redox Signaling
  72. Inflammation and Parkinson's disease pathogenesis: Mechanisms and therapeutic insight
    Gianluigi Forloni, Pietro La Vitola, Milica Cerovic, Claudia Balducci · 2020 · Progress in molecular biology and translational science
  73. Biomarkers and the Role of α-Synuclein in Parkinson’s Disease
    Tingting Du, Le Wang, Weijin Liu, Guanyu Zhu, Ying‐Chuan Chen, Jianguo Zhang · 2021 · Frontiers in Aging Neuroscience
  74. Molecular Mechanisms of Cellular Senescence in Neurodegenerative Diseases
    Lee, He-Jin, Yoon, Ye-Seul, Lee, Seung-Jae · 2023 · Journal of Molecular Biology
  75. Possible inflammatory mechanisms and predictors of Parkinson's disease patients with fatigue (Brief Review)
    Haili Wang, Yimin Liu, Jingyi Zhao, Xin Guo, Meng Hu, Yingzhu Chen · 2021 · Clinical Neurology and Neurosurgery
  76. The dual nature of neuroinflammation in networked brain
    Ludmila Müller, Svetlana Di Benedetto, Viktor Müller · 2025 · Frontiers in Immunology
  77. Transglutaminase 2 exacerbates α‐synuclein toxicity in mice and yeast
    Hilary Grosso Jasutkar, Jong‐Min Woo, Kang‐Woo Lee, Joo‐Young Im, Eliezer Masliah, Eunsung Junn, M. Maral Mouradian · 2014 · The FASEB Journal
  78. Allelic difference in Mhc2ta confers altered microglial activation and susceptibility to α-synuclein-induced dopaminergic neurodegeneration
    Itzia Jiménez-Ferrer, Michael A S Jewett, Ashmita Tontanahal, Marina Romero‐Ramos, Maria Swanberg · 2017 · Neurobiology of Disease
  79. A secret that underlies Parkinson's disease: The damaging cycle
    Feiyi Sun, Yulin Deng, Xiaowei Han, Qingqing Liu, Peng Zhang, Robina Manzoor, Hong Ma · 2019 · Neurochemistry International
  80. Size-Selective Phagocytic Clearance of Fibrillar α-Synuclein through Conformational Activation of Complement Receptor 4
    Kristian Juul‐Madsen, Per Qvist, Kirstine L. Bendtsen, Annette E. Langkilde, Bente Vestergaard, Kenneth Alan Howard, Martxel Dehesa-Etxebeste, Søren R. Paludan, Gregers Rom Andersen, Poul Henning Jensen et al. · 2020 · The Journal of Immunology
  81. Repurposing Immunomodulatory Imide Drugs (IMiDs) in Neuropsychiatric and Neurodegenerative Disorders
    Yoo Jin Jung, David Tweedie, Michael T. Scerba, Dong Seok Kim, Maria Francesca Palmas, Augusta Pisanu, Anna Rosa Carta, Nigel H. Greig · 2021 · Frontiers in Neuroscience
  82. The involvement of α-synucleinopathy in the disruption of microglial homeostasis contributes to the pathogenesis of Parkinson’s disease
    Yongzhen Miao, Hongrui Meng · 2024 · Cell Communication and Signaling
  83. Gut Microbiota and Immune System Dynamics in Parkinson’s and Alzheimer’s Diseases
    Nataša Z. Kuštrimović, Sahar Balkhi, Giorgia Bilato, Lorenzo Mortara · 2024 · International Journal of Molecular Sciences
  84. Kv1.3 inhibition attenuates neuroinflammation through disruption of microglial calcium signaling
    Alla F. Fomina, Hai Minh Nguyen, Heike Wulff · 2020 · Channels
  85. Alpha-Synuclein Induced Immune Cells Activation and Associated Therapy in Parkinson’s Disease
    Ruichen Su, Tian Gang Zhou · 2021 · Frontiers in Aging Neuroscience
  86. Role of melatonin in TLR4-mediated inflammatory pathway in the MTPT-induced mouse model
    Sendegül Yıldırım, Ayşe Özkan, Güneş Aytaç, Ayşel Ağar, Gamze Tanrιöver · 2021 · NeuroToxicology
  87. Role of the Gut–Brain Axis, Gut Microbial Composition, Diet, and Probiotic Intervention in Parkinson’s Disease
    Subramanian Thangaleela, Bhagavathi Sundaram Sivamaruthi, Periyanaina Kesika, Muruganantham Bharathi, Chaiyavat Chaiyasut · 2022 · Microorganisms
  88. Neurodegeneration and inflammation crosstalk: Therapeutic targets and perspectives
    Wael M.Y. Mohamed, Jaya Kumar, Badrah Saeed Ali Alghamdi, Al-Hassan Soliman Wadan, Toshihide Yamashita · 2022 · IBRO Neuroscience Reports
  89. Enhancing the Astrocytic Clearance of Extracellular α-Synuclein Aggregates by Ginkgolides Attenuates Neural Cell Injury
    Jun Hua, Nuo Yin, Shi Xu, Qiang Chen, Tingting Tao, Ji Zhang, Jianhua Ding, Yi Fan, Gang Hu · 2019 · Cellular and Molecular Neurobiology
  90. Targeting Microglial and Neuronal Toll-like Receptor 2 in Synucleinopathies
    Kwon, Somin, Iba, Michiyo, Masliah, Eliezer, Kim, Changyoun · 2019 · Experimental Neurobiology
  91. Clustering of human prion protein and α-synuclein oligomers requires the prion protein N-terminus
    Nadine S. Rösener, Lothar Gremer, Michael M. Wördehoff, Tatsiana Kupreichyk, Manuel Etzkorn, Philipp Neudecker, Wolfgang Hoyer · 2020 · Communications Biology
  92. Neuro-Immune Cross-Talk in the Striatum: From Basal Ganglia Physiology to Circuit Dysfunction
    Andrea Mancini, Veronica Ghiglieri, Lucilla Parnetti, Paolo Calabresi, Massimiliano Di Filippo · 2021 · Frontiers in Immunology
  93. Parkinson Disease: Translating Insights from Molecular Mechanisms to Neuroprotection
    Sheila K. Pirooznia, Liana S. Rosenthal, Valina Lynn Dawson, Ted M. Dawson · 2021 · Pharmacological Reviews
  94. Nonclinical safety evaluation, pharmacokinetics, and target engagement of Lu AF82422, a monoclonal IgG1 antibody against alpha-synuclein in development for treatment of synucleinopathies
    Lone Fjord‐Larsen, Annemette Thougaard, Karen Malene Wegener, Joan Christiansen, Frank Larsen, Lise Maj Schrøder-Hansen, Marianne Kaarde, Dorte Kornerup Ditlevsen · 2021 · mAbs
  95. Does SARS-CoV-2 affect neurodegenerative disorders? TLR2, a potential receptor for SARS-CoV-2 in the CNS
    Marcell P. Szabo, Michiyo Iba, Avindra Nath, Eliezer Masliah, Changyoun Kim · 2022 · Experimental & Molecular Medicine
  96. The neuroprotective effects of ferulic acid in toxin-induced models of Parkinson's disease: A review
    Samira Hassani, Abolghasem Esmaeili · 2024 · Ageing Research Reviews
  97. The Role of Microglia and Astrocytes in the Pathomechanism of Neuroinflammation in Parkinson’s Disease—Focus on Alpha-Synuclein
    Oliwia Harackiewicz, Beata Grembecka · 2024 · Journal of Integrative Neuroscience
  98. α‐Synuclein in Parkinson's Disease: From Bench to Bedside
    Gabriele Bellini, Vanessa D’Antongiovanni, Giovanni Palermo, Luca Antonioli, Matteo Fornai, Roberto Ceravolo, Nunzia Bernardini, Pascal Derkinderen, Carolina Pellegrini · 2024 · Medicinal Research Reviews
  99. Taming microglia: the promise of engineered microglia in treating neurological diseases
    Echo Yongqi Luo, Ryohichi Sugimura · 2024 · Journal of Neuroinflammation
  100. Tackling dipeptidyl peptidase IV in neurological disorders
    Alessandro Castorina, Ghaith Al‐Badri, Gian Marco Leggio, Giuseppe Musumeci, Rubina Marzagalli, Filippo Drago · 2018 · Neural Regeneration Research